When.com Web Search

  1. Ads

    related to: boston scientific vacantes

Search results

  1. Results From The WOW.Com Content Network
  2. Boston Scientific - Wikipedia

    en.wikipedia.org/wiki/Boston_Scientific

    Boston Scientific Corporation (BSC), headquartered in Marlborough, Massachusetts and incorporated in Delaware, [2] is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular ...

  3. Boston Scientific Corporation - Wikipedia

    en.wikipedia.org/?title=Boston_Scientific...

    Retrieved from "https://en.wikipedia.org/w/index.php?title=Boston_Scientific_Corporation&oldid=19811070"

  4. John Abele - Wikipedia

    en.wikipedia.org/wiki/John_Abele

    John E. Abele (born 1937) is an American businessman and co-founder of Boston Scientific, a medical device company. He received the ASME Medal in 2010 and, as of November 2024, has a net worth of $1.9 billion. [1] He was first listed on the Forbes 400 in 1996 as a self-made billionaire.

  5. Peter Nicholas (businessman) - Wikipedia

    en.wikipedia.org/wiki/Peter_Nicholas_(businessman)

    They borrowed $800,000 to start Boston Scientific, a manufacturer of medical devices. He helped grow the company through a series of astute acquisitions. [6] Nicholas was chief executive officer of the company until 1999, when he became chairman. He continued in that role until his retirement in 2016. [3]

  6. Category:Boston Scientific - Wikipedia

    en.wikipedia.org/wiki/Category:Boston_Scientific

    Boston Scientific; C. Cameron Health This page was last edited on 19 December 2020, at 11:44 (UTC). Text is available under the Creative Commons ...

  7. Guidant - Wikipedia

    en.wikipedia.org/wiki/Guidant

    The next day, Boston Scientific increased their bid to $25 billion, followed the next day by Johnson & Johnson increasing their bid to $24.2 billion. It was not until January 17 that Boston Scientific produced a new offer of $27.2 billion ($80 per share), with the help of Abbott Laboratories. Abbott agreed to purchase $1.4 billion of Boston ...